Frank Yocca - Chief Scientific Officer, Bioxcel Therapeutics, Inc

As of March 16, 2022


Frank Yocca Net Worth

  • Net worth is estimated to be at least $3.9M
  • Owns at least 58,397 units of Bioxcel Therapeutics, Inc stock
  • Sold an estimated value of $2.32M in the last 4 years at Bioxcel Therapeutics, Inc

Frank Yocca Trading

  • Largest purchase of shares was 6,547 units , worth over $56.76K on August 14, 2019
  • Largest sale of shares was 15,000 units , worth over $865.15K on February 18, 2021
  • In total has made about 12 transactions over 4 years
  • Usually trades in March, with the busiest year in 2018 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Frank Yocca Mailing Address

  • Mailing address is 780 East Main Street C/o Bioxcel Therapeutics, Inc. Branford CT 06405 CT

Bioxcel Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Vimal Mehta, Ph.D. 2020 $890,000 - $8,122,500 $556,250 $7,800 $9,576,550
Vimal Mehta, Ph.D. 2019 $459,000 - $1,269,131 $233,000 $7,800 $1,968,931
William P. Kane, Jr. 2020 $245,455 - $4,185,500 $138,699 - $4,569,654
Reina Benabou, M.D., Ph.D. 2020 $197,443 - $2,462,400 $76,341 - $2,736,184
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm

Bioxcel Therapeutics, Inc Insider Trading

  • The most recent transaction was 473,250 units sold on June 29, 2021 by Vimal Mehta worth over $14.59M
  • In the last 3 years, insiders at Bioxcel Therapeutics, Inc sold an estimated value of $131.43M and bought an estimated value of $19.96M
  • The most active traders are Vimal Mehta, CEO and President,  Frank Yocca, Chief Scientific Officer,  and Peter Mueller, Director
  • Insider trading is most common in March, with the busiest year in 2021

BioXcel Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1